Clinical features and outcomes of patients admitted to the ICU for Cyclophosphamide-associated cardiac toxicity: a retrospective cohort.

Alice VennierEmmanuel CanetVianney GuardiolleFlorian ReizineJean-Noël TrochuThierry Le TourneauCyrille TouzeauRoch HouotAmélie SeguinJean ReignierJean-Baptiste LascarrouJean-Marc TadiéJérémie Lemarié

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2023)

Refractory cardiogenic shock is the primary cause of death of patients with severe CY-related cardiotoxicity. Nonetheless, the cardiac function of most survivors recovered within a month.

Keyphrases

intensive care unit
low dose
young adults
left ventricular
high dose
oxidative stress
early onset
mechanical ventilation
drug induced
type diabetes
heart failure
adipose tissue
glycemic control
atrial fibrillation
oxide nanoparticles